What are the specimen collection, transport, and processing requirements for the standard SARS‑CoV‑2 RT‑PCR assay (PCR 21754)?

Specimen Collection, Transport, and Processing for SARS-CoV-2 RT-PCR (PCR 21754)

For standard SARS-CoV-2 RT-PCR testing, collect nasopharyngeal (NP) swabs using flocked synthetic fiber swabs with plastic or wire shafts, place immediately in viral transport medium, and maintain at 2-8°C if testing within 72 hours or freeze at -70°C for longer storage.

Specimen Collection

Preferred Specimen Types

The nasopharyngeal swab remains the gold standard for SARS-CoV-2 detection, though multiple specimen types are acceptable 1:

• Nasopharyngeal swabs: Highest sensitivity, collected by healthcare professionals
• Mid-turbinate swabs: Acceptable alternative with comparable performance
• Anterior nasal swabs: Suitable for both healthcare provider and supervised self-collection
• Oropharyngeal swabs: Can be combined with NP swabs in single tube

Collection Technique for Nasopharyngeal Swabs 1

1. Tilt patient's head back 70 degrees
2. Insert flexible mini-tip swab through nares parallel to palate (not upward) until:
   • Resistance is met, OR
   • Distance equals ear-to-nostril measurement
3. Gently rub and roll swab
4. Leave in place several seconds to absorb secretions
5. Slowly remove while rotating
6. Immediately place in sterile tube containing transport medium

Critical Equipment Requirements 1

Use only:

• Flocked synthetic fiber swabs
• Plastic or wire shafts

Never use:

• Calcium alginate swabs (interfere with amplification)
• Wooden shaft swabs (contain inhibitory substances)
• Rayon swabs (platform compatibility issues)

Transport Media

Acceptable Transport Media 2, 3

Multiple transport media maintain SARS-CoV-2 RNA stability equivalently:

• Universal Transport Medium (UTM)
• UTM-RT
• ESwab
• M4
• Even 0.9% saline is acceptable 2

Key finding: All tested media showed <3 cycle threshold difference across storage conditions, confirming broad compatibility 2.

Storage and Transport Conditions 2

Temperature stability (up to 14 days):

• Room temperature (18-26°C): Acceptable for most systems
• Refrigerated (2-8°C): Preferred for routine transport
• Frozen (-10 to -30°C): For extended storage

Critical caveat: At 37°C, some systems show significant RNA degradation within 96 hours 4. Avoid prolonged exposure to elevated temperatures during transport.

Processing Requirements

Pre-Analytical Considerations 5

Extraction methods must:

• Isolate high-quality viral RNA
• Remove PCR inhibitors
• Include internal amplification controls (unless inhibition rates proven <acceptable limits)

Verification requirements 5:

• If using specimen types beyond FDA-cleared claims, perform verification study
• If using different extraction protocol than manufacturer-specified, verify comparable performance
• Document recovery of target nucleic acids

Quality Control 5

All assays require:

• External positive controls (tested through all assay steps)
• External negative controls
• Internal amplification controls (added to each specimen)

Specimen Type Validation 6

While NP swabs are standard, laboratories may validate alternative specimen types:

• Sputum and BAL: Highest diagnostic sensitivity but require more PPE
• Mid-turbinate and nasal: Suitable for most cases with less PPE requirements
• Self-collected specimens: Comparable performance to healthcare provider-collected when properly supervised 1

Common Pitfalls to Avoid

1. Wrong swab type: Using cotton, calcium alginate, or wooden shaft swabs will cause false negatives
2. Improper insertion depth: Swab must reach nasopharynx, not just nasal vestibule
3. Heat exposure during transport: Keep specimens cool; avoid car trunks or direct sunlight
4. Delayed processing without proper storage: If >72 hours to testing, freeze specimens
5. Using unvalidated specimen types: Verify performance if deviating from FDA-cleared specimen types

Biosafety Considerations 4

Important distinction: Swab transport media designed for viral culture maintain SARS-CoV-2 infectivity, requiring BSL-2 or higher handling precautions. Saliva collection devices with stabilizers inactivate virus immediately.